Climate Change Data

Environmental Metrics

ESG Focus Areas

• Social
• Environmental

Social Achievements

• Intensified clinical development efforts for M1Pram and BioChaperone LisPram, aiming to improve medical service and generate weight loss in diabetic patients.
• Strengthened Board of Directors with the appointment of three new independent members.

Climate Goals & Targets

Environmental Challenges

• The spread of a Covid-19 pandemic can disrupt the activity of the Company, in particular the development of its research programs.
• The products resulting from the Company’s research are positioned in competitive and rapidly changing markets.
• The Company has a history of significant operating losses that could continue.
• The Company may need to strengthen its equity or to resort to additional financing in order to ensure its development.
• The marketing of the Company’s product candidates depends on the actions taken by its partners, which are beyond the Company’s control.
• The Company sources from third parties to obtain specific proteins in sufficient quantity and quality.
• The Company is dependent on its subcontractors to carry out its preclinical, clinical activities and manufacture of clinical batches.
• The protection of the Company’s patents and other intellectual property rights is uncertain and may be insufficient to protect it from its competitors.

Mitigation Strategies

• The Company is actively seeking partners for the mature projects in its portfolio and continues their development while nonetheless focusing its expenses on priority projects and activities.
• The Company will continue to have significant financing needs in the future for the development of its technologies and the pursuit of its strategy, but it may not be able to finance its own growth.
• The Company has developed alternative solutions but implementing them could delay the development of its innovative formulations and generate additional costs.
• The Company devotes significant financial and human resources to protecting its technologies, and employs means commonly used in the industry (such as filing additional results to expand one or more patent claims) to extend the protection of its technologies beyond application periods, although it cannot guarantee the results thereof.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Comparative bids are requested above a certain expenditure threshold.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: MiddleNext Code

Third-party Assurance: Not disclosed